Bulletin
Investor Alert

New York Markets After Hours

Topics

Flu

3:30 a.m. April 15, 2021 - By Tonya Garcia
Rite Aid reports narrower losses, sales beatRite Aid Corp. shares rose 1.3% in Thursday premarket trading after the pharmacy retailer reported a fourth-quarter sales beat. Net losses totaled $18.5 million, or 34 cents per share, after a loss of $324.7 million, or $6.08 per share, last year. Adjusted losses of 78 cents per share were ahead of the FactSet consensus for a loss of 90 cents per share. Revenue of $5.92 billion was up from $5.73 billion last year and also ahead of the FactSet consensus for $5.85 billion. The quarter was impacted by "a historically soft cough, cold and flu season, the deferral of elective procedures and related acute prescription volume and the impact of COVID-19 on selling, general and administrative expenses," Chief Executive Heyward Donigan said in a statement. For March and April to date, Rite Aid has administered two million COVID-19 vaccine shots, and Donigan said prescription trends heading back "to positive levels." For the first quarter, Rite Aid is guiding for net income between $10 million and a net loss of $10 million and retail pharmacy revenue between $6.1 billion and $6.3 billion. The company expects COVID-19 to continue to have an impact. The FactSet consensus is for pharmacy sales of $6.084 billion. Rite Aid stock is up 20.3% for the year to date while the S&P 500 index [s spx] has gained 9.8% for the period.
3:26 a.m. March 31, 2021 - By Tonya Garcia
Walgreens sales miss expectations after weak cold and flu seasonWalgreens Boots Alliance Inc. reported fiscal second-quarter net income of $1.03 billion, or $1.19 per share, up from $946.0 million, or $1.07 per share last year. Adjusted EPS of $1.40 beat the FactSet consensus for $1.10 per share. Sales of $32.78 billion were up from $31.34 billion last year but below the FactSet consensus for $36.59 billion. Walgreens total excludes sales from discontinued operations of $4.8 billion. Comparable sales in the U.S. fell 3.5% due to a weak cough, cold and flu season. Comp sales for Boots UK fell 17.9% as COVID-19 restrictions reduced foot traffic on major high streets and transportation hubs. "Overall, we have achieved a good financial quarter with results well ahead of expectations, despite significant impacts from COVID-19, and we have raised our full-year EPS guidance," said Walgreens' new Chief Executive Roz Brewer in a statement. The former Starbucks Corp. executive assumed the role on . "I am optimistic about our ability to drive sustainable, long-term value for our shareholders, while acknowledging that there is still work to be done to stabilize the base business." Walgreens raised its fiscal 2021 adjusted EPS guidance to mid-to-high single digit growth in constant currency from low single-digit growth. The pharmacy retailer also expects the $6.5 billion divestiture of to be complete before the end of the fiscal year. Walgreens says it has administered eight million COVID-19 vaccinations and conducted five million COVID-19 tests. Walgreens stock rose 2.6% in Wednesday premarket trading and have gained 15.8% over the past year. The S&P 500 index is up 53.2% for the last 12 months.
4:10 a.m. Feb. 17, 2021 - By Jaimy Lee
Vir, GSK ink new R&D deal Shares of Vir Biotechnology Inc. were up 12.8% in premarket trading on Wednesday after the company said it would expand its research agreement with GlaxoSmithKline to include the flu and other respiratory diseases. As part of the deal, GSK will pay Vir $225 million upfront and will make an equity investment of $120 million in the biotech; it also has the option to develop one drug for $300 million, with the possibility of an additional $200 million in milestone payments. The companies had initially engaged in a deal in 2020 that is focused on studying treatments for coronaviruses, including SARS-CoV-2. One experimental COVID-19 treatment that the companies are already developing is VIR-7831, which is being tested in Phase 3 studies as a monotherapy and in a mid-stage trial as a combination therapy. Vir's stock has soared 287.7% over the past 12 months, while the broader S&P 500 is up 16.%.
11:02 a.m. Jan. 15, 2021 - By Ciara Linnane
Global deaths from COVID-19 top 2 million as U.S. suffers most weekly fatalities since start of the pandemic Weekly deaths exceed CDC’s estimate for flu-related deaths for entire 2019-2020 season The global case tally for the coronavirus-borne illness COVID-19 climbed above 93 million on Friday and the death toll climbed above 2 million, with the U.S. leading all nations by cases and fatalities.
10:21 a.m. Jan. 13, 2021 - By Ciara Linnane
U.S. sees record one-day death toll and experts worry new variant may make activities like plane travel more risky Vaccine program must speed up to avoid reaching 640,000 deaths by spring, equal to lives lost in the 1918 flu pandemicThe U.S. set another grim milestone in the coronavirus pandemic on Tuesday, when more than 4,400 COVID-19 patients died, the most in a single day since the start of the outbreak, and experts said that with cases continuing to accelerate, the worst is still to come.
3:42 a.m. Jan. 11, 2021 - By Jaimy Lee
Moderna to develop vaccine candidates for seasonal flu, HIVShares of Moderna Inc. were up 1.3% in premarket trading on Monday after the company said it plans to launch new development programs using its mRNA technology that will focus on developing vaccines for seasonal flu, HIV, and the Nipah virus. This follows the success of its mRNA COVID-19 vaccine, which is one of two vaccines to be authorized so far in the U.S. CEO Moderna also said it plans to expand its respiratory syncytial virus to include older adults, and it plans to test different vaccine combinations that fight the flu, COVID-19, RSV, and human metapneumovirus. "The uniquely challenging year of 2020 for all of society proved to be an extraordinary proof-of-concept period for Moderna," CEO Stéphane Bancel said in a news release. As part of its corporate update, Moderna said it had about $5.2 billion in cash as of Dec. 31, compared to the $1.2 billion in cash it had at the same time a year ago, and it expects to generate at least $11.7 billion in revenue in 2021 for its COVID-19 vaccine based on advance purchase agreements. Moderna's stock has soared 489.1% over the last year, while the S&P 500 is up 19.7%.
2:18 a.m. Dec. 7, 2020 - By Quentin Fottrell
Joe Biden’s pandemic plan: Restore Obamacare, mandatory masks, paid sick leave and free COVID-19 tests The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face’The President-elect said: ‘Dealing with the coronavirus pandemic is one of the most important battles our administration will face.’
3:01 a.m. Nov. 29, 2020 - By Andrew Keshner
Americans pay more for prescription drugs than anyone else. Can Amazon Pharmacy change that? What the e-commerce behemoth’s entry into the pharmacy business could mean for consumers’ health and wealthWhat the e-commerce behemoth’s entry into the pharmacy business could mean for consumers’ health and wealth
11:10 a.m. Nov. 24, 2020 - By Ciara Linnane
U.S. is ‘in the middle of the Fight of the Century,’ says former CDC head as cases rise in 45 states, hospitalizations set record U.S. has averaged 173,147 cases a day in the past week, and more than 85,000 COVID-19 patients are in a hospitalThe U.S. case tally from the coronavirus illness COVID-19 climbed above 12.84 million on Tuesday and hospitalizations again reached record levels, with 45 states reporting rising infections.
2:42 a.m. Nov. 9, 2020 - By Jaimy Lee
To defeat COVID-19, ‘we need a unified national strategy,’ says public health expert Dr. Howard Koh Koh served as assistant secretary of health during the H1N1 flu pandemic in 2009Dr. Howard Koh knows what it’s like to be a government official running a pandemic response.
4:10 a.m. Oct. 19, 2020 - By Jaimy Lee
CVS to hire 15,000 workers as it pushes for pharmacy techs to be allowed to administer vaccinesShares of CVS Health Corp. gained 0.6% in premarket trading on Monday after the retail giant announced plans to hire 15,000 full-time and part-time workers in the fourth quarter as it prepares for rising cases of COVID-19 and flu season. Two-thirds of the jobs are for licensed pharmacy technicians, a group of professionals that CVS wants to be allowed to administer COVID-19 vaccines, if and when they become available. There are currently only six states - Idaho, Michigan, Nevada, Rhode Island, Utah, and Washington - that allow pharmacy technicians to administer vaccines, according to a CVS spokesperson. The company is also looking to fill jobs for pharmacists, nurses, physician assistants, and distribution center and customer-service workers. The Trump administration on Friday with CVS and Walgreens Boots Alliance Inc. for the drugstore chains to administer COVID-19 vaccines to residents of long-term care facilities in the future. Shares of CVS are down 19.8% for the year, while the S&P 500 is up 7.8%.
3:21 a.m. Oct. 18, 2020 - By Quentin Fottrell
Dr. Fauci: ‘This is an outbreak of historic proportions, the likes of which we’ve not seen in 102 years’ The veteran immunologist said, ‘I think we’re facing a whole lot of trouble’The veteran immunologist said, ‘I think we’re facing a whole lot of trouble.’
12:34 p.m. Oct. 1, 2020 - Associated Press
Flu vaccine expected to be in high demand as U.S. and Europe aim to ward off ‘twindemic’ A record number of doses are on the way — between 194 million and 198 million for the U.S. aloneA record number of doses are on the way — between 194 million and 198 million for the U.S. alone.
3:27 a.m. Sept. 28, 2020 - By Jaimy Lee
There are four coronavirus vaccines in late-stage studies — here’s how they differ The vaccine candidates vary on everything from refrigeration needs to effectiveness goals and number of dosesJohnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so and providing additional details that can help investors differentiate the pool of late-stage coronavirus vaccines.
3:30 a.m. Sept. 21, 2020 - By Jaimy Lee
Philadelphia pediatrician Paul Offit: Prepare to wear masks and socially distance even after getting COVID-19 vaccine Dr. Paul Offit of the Children’s Hospital of Philadelphia co-invented the rotavirus vaccineDr. Paul Offit, a pediatrician at Children’s Hospital of Philadelphia and a co-inventor of the rotavirus vaccine, told friends not to worry about the coronavirus. “I am on the record as being dead wrong about this,” he said.
11:57 p.m. Sept. 20, 2020 - By Quentin Fottrell
Dr. Fauci: ‘We may be able to put this coronavirus outbreak behind us’ — but he says Americans must play a critical role COVID-19 has now infected more than 30 million people worldwide COVID-19 has now infected more than 30 million people worldwide.
4:07 a.m. Sept. 17, 2020 - By Jaimy Lee
Moderna to start developing a seasonal flu vaccineShares of Moderna Inc. gained 3.8% in premarket trading on Thursday after the company said it plans to start developing a seasonal flu vaccine. "We are increasing our investment in vaccines and we will develop a seasonal flu vaccine given the unmet need for highly effective vaccines," Moderna CEO Stéphane Bancel said in a news release. The preclinical company is currently running a Phase 3 clinical trial for its mRNA COVID-19 vaccine candidate. Moderna's stock has soared 251.9% this year, while the S&P 500 is up 4.8%.
2:13 a.m. Sept. 15, 2020 - By Jaimy Lee
Here’s what you need to know about clinical trials as drug makers push forward with coronavirus vaccine studiesWhether you’re new to investing in pharmaceutical or biotechnology companies or simply paying close attention to the race to develop a COVID-19 vaccine, here’s what you need to know to understand how clinical trials work.
5:13 a.m. Sept. 9, 2020 - By Lina Saigol
AstraZeneca stock falls as drugmaker pauses vaccine trial after volunteer’s ‘unexplained illness’ Social gatherings above six set to be banned in England after sharp rise in daily coronavirus casesNews comes as England set to announce new measures to curb the spread of the virus after a sharp rise in cases.
11:23 a.m. Sept. 6, 2020 - By Quentin Fottrell
Sweden embraced herd immunity, while the U.K. abandoned the idea — so why do they both have high COVID-19 fatality rates? ‘Sweden’s prized herd immunity is nowhere in sight,’ according to an analysis in the Journal of the Royal Society of Medicine‘Sweden’s prized herd immunity is nowhere in sight,’ according to an analysis in the Journal of the Royal Society of Medicine.
11:44 a.m. Aug. 25, 2020 - By Quentin Fottrell
COVID-19 and 1918 ‘Spanish flu’ have one depressing thing in common A new working paper looks at the effects of the 1918 influenza and COVID-19 pandemics on mortality and the economy, plus the role of non-pharmaceutical interventionsA new working paper looks at the effects of the 1918 influenza and COVID-19 pandemics on mortality and the economy, plus the role of non-pharmaceutical interventions.
5:37 a.m. Aug. 15, 2020 - By Ronald D. Fricker Jr.
The ‘excess deaths’ tally in the U.S. is 204,691 in 7 months — so COVID-19 deaths might be undercounted The number of excess deaths exceeds the number attributable to COVID-19 by more than 16,000 peopleThe number of deaths through July 2020 is 8% to 12% higher than it would have been if the coronavirus pandemic had never happened.
3:52 a.m. Aug. 15, 2020 - By Nicole Lyn Pesce
CDC director warns America is in for the ‘worst fall … we’ve ever had’ Continued coronavirus spikes aren’t the only public health crisis looming this autumn The coronavirus isn’t the only public health crisis looming this autumn.
3:06 p.m. Aug. 12, 2020 - By Quentin Fottrell
Dr. Fauci says Russia risks ‘hurting a lot of people’ by rushing coronavirus vaccine ‘Having a vaccine, and proving that a vaccine is safe and effective, are two different things,’ he told ABC News‘Having a vaccine, and proving that a vaccine is safe and effective, are two different things,’ he told ABC News.
7:52 a.m. Aug. 12, 2020 - By Quentin Fottrell
Dr. Fauci tells Americans to be mindful of these important limitations about any future coronavirus vaccine ‘You must never abandon the public-health approach,’ Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told a live streamed Q&A‘You must never abandon the public-health approach,’ Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told a live streamed Q&A.
4:23 p.m. Aug. 10, 2020 - By Tomi Kilgore
Coronavirus update: U.S. case tally tops 5 million, more than one-quarter of the 20 million global cases Georgia high school closes after in wake of viral video of crowded hallway with very few masks; Dr. Fauci tempers enthusiasm over potential vaccine’s effectivenessThe U.S. reached another milestone on Monday in confirmed cases of the coronavirus that causes COVID-19, as the case tally topped 5 million, which is more than one-quarter of the global total of more than 20 million cases, as uncertainties over the U.S. response continue to grow.
12:58 a.m. Aug. 10, 2020 - By Sherri Snelling
Could flu vaccines lower your risk of Alzheimer’s? Research sheds new light Two studies released at the Alzheimer’s Association conference indicate a possible connection between flu and pneumonia shots with reducing or delaying cognitive declineThe studies show ‘vaccines are strongly associated with lower prevalence of dementia,’ says one scientist.
7:04 a.m. Aug. 8, 2020 - By Nicole Lyn Pesce
‘Will the public be ready for a vaccine?’ Many Americans say they won’t get the coronavirus vaccine if one is developed Surveys show people are divided along political and state lines about trusting a COVID-19 vaccine Surveys show people are divided along political and state lines about trusting a COVID-19 vaccine
5:11 a.m. Aug. 8, 2020 - By Jaimy Lee
This Seattle man volunteered to be injected with an experimental COVID-19 vaccine: ‘It was kind of my duty as a healthy individual to step up’ Neal Browning is one of the volunteers who signed up to receive Moderna’s experimental COVID-19 vaccineNeal Browning, a 46-year-old network engineer at Microsoft Corp., was one of the first people in the U.S. to receive a dose of Moderna Inc.’s experimental COVID-19 vaccine.
3:24 a.m. Aug. 7, 2020 - By Ciara Linnane
Four ex-FDA commissioners urge U.S. to step up efforts to collect blood plasma for clinical trials as COVID-19 treatment ‘While vaccine development continues, it’s important to advance every promising treatment option to improve the odds for those who become sick,’ scientists write in op-edA group of four former U.S. Food and Drug Administration commissioners is arguing for the U.S. to step up efforts to collect blood plasma from patients who have recovered from the coronavirus illness COVID-19 and to push ahead with clinical trials.
6:59 a.m. Aug. 1, 2020 - By Jaimy Lee
Dr. Osterholm: Americans will be living with the coronavirus for decades Dr. Michael Osterholm, epidemiologist at the University of Minnesota, recognized the coronavirus would become a pandemic as early as JanuaryOn Jan. 20, just nine days after Chinese health authorities published the DNA sequence for a new coronavirus that was causing concern in China, Dr. Michael Osterholm, an epidemiologist at the University of Minnesota, wrote in an email: “I’m certain this will cause our next pandemic.”
1:50 p.m. July 22, 2020 - By V.L. Hendrickson 
How NYC hospitals have become better equipped to treat COVID-19 patients Knowledge, equipment and experience have translated into more New Yorkers surviving the coronavirusTo combat the virus, researchers have been pushing innovations in testing, drugs and blood plasma and other treatments.
6:02 a.m. July 16, 2020 - By Jaimy Lee
Dynavax, Mount Sinai to work on universal flu vaccineShares of Dynavax Technologies Corp. gained 0.2% in trading on Thursday after the company announced that it will work with the Icahn School of Medicine at the Mount Sinai hospital system in New York on a universal influenza vaccine. Mount Sinai has received funding from the National Institute of Allergy and Infectious Diseases to develop a vaccine and aims to use Dynavax's adjuvant technology to support that process. A universal flu vaccine would get rid of the need for annual flu vaccination, the organizations said in a news release. Dynavax's stock has gained 64.1% so far this year, driven largely by the company's work on a COVID-19 vaccine. The S&P 500 is down 0.1% year-to-date.
4:57 a.m. July 16, 2020 - By Bruce Y. Lee
This new study shows how well a coronavirus vaccine must work before we can stop social distancing A COVID-19 vaccine needs to be much more effective than a flu shotA COVID-19 vaccine needs to be much more effective than a flu shot.
5:49 a.m. July 14, 2020 - By Quentin Fottrell
Here’s one ‘remarkable’ difference between COVID-19 and the 1918 Spanish flu There are also similarities between the 1918 influenza and SARS-CoV-2, the coronavirus that originated in Wuhan, ChinaThere are also similarities between the 1918 influenza and SARS-CoV-2, the coronavirus that originated in Wuhan, China.
1:01 p.m. July 8, 2020 - By Quentin Fottrell
‘Now we’re seeing the consequence of community spread’: Fauci says Americans must do 3 things to beat COVID-19 ‘What we saw were a lot of people who maybe felt that because they think they are invulnerable,’ says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases‘What we saw were a lot of people who maybe felt that because they think they are invulnerable,’ says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
7:57 a.m. July 4, 2020 - By Quentin Fottrell
5 critical mistakes that created the biggest public-health crisis in a generation Don’t wear a mask! Everyone should wear masks!100 days of the COVID-19 pandemic: Don’t wear a mask! Everyone should wear masks!
10:06 a.m. June 29, 2020 - By Jaimy Lee
Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed ‘People, companies are starting to plan to make doses even before, you know, the vaccine works,’ Dr. Anthony Fauci said Tuesday on Capitol HillInovio Pharmaceuticals Inc. has yet to share results from the Phase 1 trial for its COVID-19 vaccine candidate, but has already received millions of dollars in funding to scale up manufacturing capacity.
7:42 p.m. June 22, 2020 - By Quentin Fottrell
‘We are filling the stockpile in anticipation of a possible problem in the fall’: Government preparing for coronavirus second wave Coronavirus cases in the U.S. have surpassed 2.2 million, and there are record daily highs in half-a-dozen statesCoronavirus cases in the U.S. have surpassed 2.2 million, and there are record daily highs in half-a-dozen states.
9:14 a.m. June 15, 2020 - By Quentin Fottrell
Yes, America needs to brace itself for a second wave of coronavirus Coronavirus cases in the U.S. have surpassed 2 million, and have risen by double-digit percentages in 16 U.S. states that have loosened restrictions since Memorial DayCoronavirus cases in the U.S. have surpassed 2 million, and have risen by double-digit percentages in 16 U.S. states that have loosened restrictions since Memorial Day.
Browse topics:

Filter results by

Location

Us (252)

Asia Pacific (45)

Europe (42)

China (36)

Eu (32)

Latin America (9)

Link to MarketWatch's Slice.